Platelet transfusion is a common aspect of blood donation for the treatment of various health conditions. Apheresis platelet transfusion is special because of its working mechanism that differs from regular blood transfusion. Apheresis is an essential medical technology, wherein blood is passed through a special apparatus and separated to take away particular constituents. The rest of the blood is then returned to the regular circulation. This process is also considered as extra-corporeal therapy. Increasing demand for blood plasma and growing awareness about blood donation amongst people are some of the greatest drivers for the global apheresis market.
Segmentation in Apheresis Technology Market
The process of apheresis works by leveraging on membrane separation and centrifugation technologies that segregate blood components and take away only the desired constituents. The market has vast segmentation, which is largely based on the types of procedures, applications, technology, products, end users and geographical demands. Apheresis takes place with help of two basic technologies, which include centrifugation and membrane separation. Devices and disposables are the two popular products types available in the industry. As far as end users of apheresis technology are concerned, they include blood banks, blood collection centers, hospitals and their attached blood banks. Based on geographical demand patterns, the global market is segmented into four regions, namely, North America, Asia, Europe and rest of the world.
Following are the types of applications:
- Others: which include lipidpheresis, Immunoadsoption and photopheresis
Following are the types of apheresis procedures:
- Donor apheresis
- Therapeutic apheresis: This segment is further divided into five sub-segments:
- Blood disorders like leukemia, TTP, etc.
- Metabolic disorders
- Neurologic disorders
- Renal diseases
- Others include hyperviscosity syndrome, malaria, rheumatic disorders, etc.
Forecasting Reports till 2017
According to the researchers, the global apheresis market is expected to grow at an estimated CAGR of 11% from 2012 to 2017. At this expected compound annual growth rate, the industry is expected to become worth $1,922.4 million by 2017. In 2012, the market was worth $1,140.8 million. Based on geographical demands, North America is expected to be the dominating segments in the world. It holds as much as 50% of total market shares, which is closely followed by Europe. However, according to the forecasting reports, emerging markets like Asia and countries from rest of the world are expected to perform better within the report timeframe. Advantages of apheresis collection over whole blood collection, increased rate of blood donation, growing awareness towards blood donation, growing demands for plasma collection and fractionation, etc. drivers are expected to influence the global market for apheresis technology.